RenovaCare (RCAR)

RenovaCare Inc. is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its initial product under development targets the body’s largest organ, the skin. The company’s flagship technology, the CellMist™ System, uses its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds.

Company profile

Ticker

RCAR

Exchange

OTC

Website

renovacareinc.com

CEO

Harmel S. Rayat

Incorporated

Nevada

Location

Arizona

Fiscal year end

Dec 31

Sector

Health Technology > Biotechnology

Industry (SIC)

Surgical & Medical Instruments & Apparatus

3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...

Former names

AMERICAN ALLIANCE CORP, ENTHEOS TECHNOLOGIES INC, Janus Resources, Inc., WHATSONLINE COM INC

SEC CIK

0001016708

Corporate docs

Articles of Incorporation & Bylaws

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

IRS number

980170247

RCAR stock data

1M 1Y 5Y

Calendar

12 Aug 22

16 Aug 22

31 Dec 22

Financial summary

Financial statements Chart RCAR financial data

Quarter (USD)	Jun 22	Mar 22	Dec 21	Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	243.96K	243.96K	243.96K	243.96K	243.96K	243.96K
Cash burn (monthly)	541.97K	217.1K	709.55K	638.19K	541.97K	408.25K
Cash used (since last report)	851.2K	340.98K	1.11M	1M	851.2K	641.19K
Cash remaining	-607.25K	-97.02K	-870.45K	-758.37K	-607.25K	-397.23K
Runway (months of cash)	-1.1	-0.4	-1.2	-1.2	-1.1	-1.0

Beta Read what these cash burn values mean

Financial data from RenovaCare earnings reports.

Institutional ownership, Q2 2021

RCAR institutional ownership history Ownership history

0.0% owned by funds/institutions

13F holders	Current	Change
Total holders	1	NEW
Opened positions	1	NEW
Closed positions	0
Increased positions	0
Reduced positions	0

13F shares	Current	Prev Q	Change
Total value	10K	0	NEW
Total shares	5K	0	NEW
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Captrust Financial Advisors	5K	$10K	NEW

Largest transactions	Shares	Bought/sold	Change
Captrust Financial Advisors	5K	+5K	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Shire • Mimedx • Organogenesis

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: agreed, Arizona, Clark, Confidential, conspiracy, County, Cutler, decline, depreciation, disbursement, disposed, Dorr, dosposal, equipment, facility, Fire, funiture, Hale, Helen, inclusion, intangible, Judicial, leasehold, LLP, lodging, Medrano, National, Peter, Pickering, remain, remaining, renewed, Rigsby, satisfaction, Settlement, solvent, strain, Superior, temporarily, title, transaction, Union, Wilmer, WilmerHale

Removed: expiring, measurement, slightly, space

From filing 10-Q 2022 Q2

Financial reports

View all